我们的服务
新品专区
MRT-2359
低至 ¥ 916.00 /1mg
Orforglipron
低至 ¥ 1080.00 /5mg
KT-474
低至 ¥ 873.00 /1mg
Sotorasib/索托拉西布
AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor, which locks KRAS G12C in an inactive GDP-bound state. AMG-510 selectively targets the KRAS p.G12C mutant and shows anti-tumor activity.
低至 ¥ 1158.00 /5mg
MRTX1133
低至 ¥ 4851.00 /10mg
Emavusertib
CA-4948 is a selective and orally bioavailable IRAK4 Inhibitor. It exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation.
低至 ¥ 540.00 /5mg
Zabedosertib
低至 ¥ 468.00 /1mg
Zimlovisertib
PF-06650833 is an inhibitor ofInterleukin-1 receptor associated kinase 4 (IRAK4), and used to treat diseases such as rheumatoid arthritis, lupus, and lymphomas.
低至 ¥ 7380.00 /100mg
Danuglipron
PF-06882961 is a potent and orally bioavailable GLP-1R agonist.
低至 ¥ 530.00 /1mg
Eragidomide
低至 ¥ 990.00 /10mg
ARS-853
ARS-853 is an inhibitor of KRAS G12C with IC50 of 2.5 μM.
低至 ¥ 765.00 /1mg
Adagrasib
MRTX849 is a potent, selective and covalent K-Ras (G12C) inhibitor that exhibits favorable drug-like properties, selectively modifies mutant cysteine 12 in GDP-bound K-Ras (G12C), and inhibits KRAS-dependent signaling.
低至 ¥ 370.00 /1mg
共 12 条了解详情 >
资讯中心